This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Aegerion Pharmaceuticals Inc (AEGR)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 375.94M 61.01M 37.17M 26.37M
Receivables 17.12M 7.57M 0.00 0.00
Inventories 9.51M 1.64M 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 407.42M 140.51M 83.75M 74.08M
Property, Plant & Equipment, Gross 4.71M 2.40M 1.42M 623.31K
Accumulated Depreciation & Depletion n.a. 745.00K 276.00K 96.96K
Property, Plant & Equipment, Net 4.71M 1.65M 1.14M 526.35K
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 5.32M 164.00K 198.00K 965.19K
Total Non-Current Assets 10.03M 1.82M 1.34M 1.49M
Liabilities & Shareholder Equity
Total Assets 417.46M 142.33M 85.09M 75.57M
Accounts Payable 36.36M 4.14M 4.95M 2.80M
Short Term Debt 3.46M 3.58M 3.02M 1.88M
Other Current Liabilities 0.00 0.00 0.00 164.14K
Total Current Liabilities 254.67M 24.84M 16.93M 9.40M
Long Term Debt 555.00K 4.01M 7.59M 8.12M
Deferred Income Taxes n.a. 0.00 0.00 0.00
Other Non-Current Liabilities 1.94M 445.00K 173.00K 841.43K
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 2.49M 4.46M 7.76M 8.97M
Total Liabilities 257.16M 29.30M 24.69M 18.37M
Preferred Stock Equity n.a. 0.00 0.00 0.00
Common Stock Equity 160.30M 113.03M 60.40M 57.20M
Common Par n.a. 29.00K 25.00K 21.30K
Additional Paid In Capital 0.00 369.06M 253.21M 187.69M
Cumulative Translation Adjustment n.a. 0.00 0.00 0.00
Retained Earnings 0.00 -256.08M -192.72M -130.46M
Treasury Stock n.a. 0.00 0.00 -373.00
Other Equity Adjustments 160.30M 28.00K -112.00K -48.00K
Total Capitalization 160.85M 117.04M 67.99M 65.33M
Total Equity 160.30M 113.03M 60.40M 57.20M
Total Liabilities & Stock Equity 417.46M 142.33M 85.09M 75.57M
Total Common Shares Outstanding 28.44M 29.38M 25.49M 21.20M
Preferred Shares n.a. 0.00 0.00 0.00
Treasury Shares n.a. 104.00K 104.00K 103.76K
Basic Weighted Shares Outstanding 29.08M 28.88M 23.56M 19.41M
Diluted Weighted Shares Outstanding 29.08M 28.88M 23.56M 19.41M
Number of Employees NA 217 98 33
Number of Part-Time Employees NA 0 0 0

AEGR Aegerion Pharmaceuticals Inc

Analysts Ratings for AEGR

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 5 5 5 5
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0

Brokerage Partners

AEGR Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs